外周单核细胞计数与年龄相关性黄斑变性:同仁健康体检研究
该横断面研究纳入2017至2019年北京同仁医院健康体检的7719名中国成年人,评估外周血单核细胞计数与年龄相关性黄斑变性(AMD)患病率的关联。多因素分析显示,单核细胞计数升高与任何AMD、中期及晚期AMD患病率升高独立相关,50-59岁年龄组关联最强。
要点
- 单核细胞计数≥0.5×10⁹/L者任何AMD风险较0.1-0.4×10⁹/L者增加1.45倍。
- 单核细胞计数升高与中期/晚期AMD合并患病率升高相关,50-59岁组OR最高。
- 高龄、高血钙、高HDL及低脂蛋白a亦与任何AMD患病率独立相关。
核心结论
- 外周单核细胞计数升高与早期、中期、晚期及任何AMD患病率升高相关,提示单核细胞可能参与AMD发病机制。
研究设计与样本
- 横断面研究,纳入2017至2019年北京同仁医院健康体检的7719名参与者,平均年龄60.5±8.1岁,年龄范围50-97岁,进行详细内科及眼科检查(含眼底照相),AMD按Beckman Initiative指南评估。
主要发现
- 任何AMD患病率为1607/7719(20.8%;95%CI:20.1%,21.9%)。
- 早期AMD患病率为832/7719(10.8%;95%CI:10.1%,11.5%)。
- 中期AMD患病率为733/7719(9.5%;95%CI:8.9%,10.2%)。
- 晚期AMD患病率为42/7719(0.50%;95%CI:0.40%,0.70%)。
- 多因素分析中,任何AMD患病率随单核细胞计数升高而增加(OR:3.49;95%CI:2.26,5.38;P<.001),调整因素包括年龄(OR:1.06;95%CI:1.05,1.07;P<.001)、血钙(OR:2.52;95%CI:1.32,4.84;P=.005)、高密度脂蛋白(OR:1.39;95%CI:1.19,1.61;P<.001)及脂蛋白a(OR:0.99;95%CI:0.98,0.99;P=.02)。
关键数值与推荐
- 单核细胞计数≥0.5×10⁹/L者较0.1-0.4×10⁹/L者任何AMD风险增加1.45倍(OR:1.45;95%CI:1.27,1.64;P<.001)。
- 单核细胞计数≥0.5×10⁹/L者较0.1-0.4×10⁹/L者中期/晚期AMD风险增加1.58倍(OR:1.58;95%CI:1.33,1.87;P<.001)。
- 50-59岁年龄组中,单核细胞计数升高与任何AMD关联的OR为4.35(P<.001),与中期/晚期AMD关联的OR为6.14(P<.001)。
临床怎么用
- 在健康体检人群中,外周血单核细胞计数升高可提示AMD风险增加,尤其对50-59岁人群。
- 对单核细胞计数≥0.5×10⁹/L者,可考虑加强眼底筛查以早期发现AMD。
局限性
- 横断面设计无法确定单核细胞计数与AMD的因果关系。
- 研究结论基于中国健康体检人群,外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess potential associations between the prevalence of age-related macular degeneration (AMD) and systemic parameters in a Chinese population. DESIGN: Cross-sectional study. METHODS: The Tongren Health Care Study included individuals attending regular health care check-up examinations in the Beijing Tongren Hospital from 2017 to 2019. Detailed medical examinations and ophthalmic examinations were applied, including fundus photography. AMD was evaluated according to the Beckman Initiative guidelines. RESULTS: The study included 7,719 participants (mean age: 60.5 ± 8.1 years; range: 50-97 years). The prevalence of any, early, intermediate, and late AMD was 1,607 of 7,719 (20.8%; 95% confidence interval [CI]: 20.1%, 21.9%), 832 of 7,719 (10.8%; 95% CI: 10.1%, 11.5%), 733 of 7,719 (9.5%; 95% CI: 8.9%, 10.2%), and 42 of 7,719 (0.50%; 95% CI: 0.40%, 0.70%), respectively. In multivariate analysis, the prevalence of any AMD increased with higher blood monocyte count (odds ratio [OR]:3.49; 95% CI: 2.26, 5.38; P < .001), after adjusting for older age (OR: 1.06; 95% CI: 1.05, 1.07; P < .001), higher serum concentration of calcium (OR: 2.52; 95% CI: 1.32, 4.84; P = .005), high-density lipoproteins (OR: 1.39; 95% CI: 1.19, 1.61; P < .001), and lower lipoprotein a (OR: 0.99; 95% CI: 0.98, 0.99; P = .02). Similar findings were obtained for the prevalence of intermediate and late AMD combined. The association between higher monocyte count and higher AMD prevalence showed the highest odds ratio for the age group of 50-59 years (any AMD: OR: 4.35, P < .001; intermediate and late AMD: OR: 6.14, P < .001). Individuals with a monocyte count of ≥0.5 × 109/L as compared to participants with a monocyte of 0.1-0.4 × 109/L had a 1.45-fold increased risk for any AMD (OR: 1.45; 95% CI: 1.27, 1.64; P < .001) and 1.58 fold increase risk for intermediate/late AMD (OR: 1.58; 95% CI: 1.33, 1.87; P < .001). CONCLUSION: A higher prevalence of early AMD, intermediate AMD, late AMD, and any AMD was associated with a higher peripheral monocyte count. In agreement with previous studies, the observation suggests monocytes playing a role in the pathogenesis of AMD.
引用
- Xue CC, Cui J, Gao LQ, et al. Peripheral Monocyte Count and Age-Related Macular Degeneration. The Tongren Health Care Study. Am J Ophthalmol. 2021. PMID: 33737032. doi:10.1016/j.ajo.2021.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。